Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.
ADVANCED SEARCH
Log in
Top
European Journal of Nuclear Medicine and Molecular Imaging
Literature
1.
Kitahara CM, Berrington de Gonzalez A, Bouville A, et al. Association of radioactive iodine treatment with cancer mortality in patients with hyperthyroidism. JAMA Intern Med. Published online July 1, 2019.
2.
Melo DR, Brill AB, Zanzonico P, Vicini P, et al. Organ dose estimates for hyperthyroid patients treated with (131)I: an update of the thyrotoxicosis follow-up study. Radiat Res. 2015;184:595–610.CrossRef
3.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2019. CA Cancer J Clin. 2019;69:7–34.CrossRef
4.
5.
Endogenous Hormones and Breast Cancer Collaborative Group, Key TJ, Appleby PN, et al. Sex hormones and risk of breast cancer in premenopausal women: a collaborative reanalysis of individual participant data from seven prospective studies. Lancet Oncol. 2013;14:1009–19.CrossRef
6.
Bradley CJ, Given CW, Roberts C. Race, socioeconomic status, and breast cancer treatment and survival. J Natl Cancer Inst. 2002;94:490–6.CrossRef
Metadata
Title
Regarding the manuscript entitled “Association of Radioactive Iodine Treatment With Cancer Mortality in Patients With Hyperthyroidism”
Authors
Xin Zhang
Guangliang Shan
Qiang Liu
Yansong Lin
Publication date
01-11-2019
Publisher
Springer Berlin Heidelberg
Published in
European Journal of Nuclear Medicine and Molecular Imaging / Issue 12/2019
Print ISSN: 1619-7070
Electronic ISSN: 1619-7089
DOI
https://doi.org/10.1007/s00259-019-04522-1

Other articles of this Issue 12/2019

European Journal of Nuclear Medicine and Molecular Imaging 12/2019 Go to the issue

Original Article

Long-term outcome of rare oncocytic papillary (Hürthle cell) thyroid carcinoma following (adjuvant) initial radioiodine therapy

Editorial

The 70th anniversary of automated radionuclide imaging

Original Article

IDH-wildtype glioblastomas and grade III/IV IDH-mutant gliomas show elevated tracer uptake in fibroblast activation protein–specific PET/CT

Original Article

177Lu-labeled low-molecular-weight agents for PSMA-targeted radiopharmaceutical therapy

Original Article

Gender-related differences in side-effects and hemodynamic response to regadenoson in patients undergoing SPECT myocardial perfusion imaging

Image of the Month

Incidental pulmonary embolism detected on workup for Y-90 SIRT